MFC Stock Analysis: Manulife Financial | NYSE
Insurance - Life | NYSE, USA | Market Cap: 70.468m USD | 12M Return: 47.7% | CA56501R1064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 111M
EPS Trend: 29.4%
Qual. Beats: 0
Rev. Trend: 22.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Manulife Financial Corporation is a Canadian-based diversified financial services provider operating across the United States, Canada, Asia, and other international markets. It is classified within the Life & Health Insurance sub-industry of the Financials sector and reports through three business segments: Wealth and Asset Management Businesses, Insurance and Annuity Products, and Corporate and Other.
The Wealth and Asset Management segment serves retirement, retail, and institutional clients through affiliated agents and brokers, independent securities firms, financial advisors, pension consultants, and banks. The Insurance and Annuity Products segment offers individual life insurance, long-term care insurance, annuities, and deposit and credit products, distributed via insurance agents, brokers, banks, financial planners, and direct marketing. Life insurers typically allocate premiums across long-duration and alternative assets to match the timing and inflation sensitivity of their policyholder obligations.
The Corporate and Other segment includes property and casualty reinsurance, run-off reinsurance operations (variable annuities and accident and health), and the companys timberland and agricultural portfolios-an alternative-asset class insurers use to diversify returns and back long-dated liabilities. Manulife also engages in investment counseling, mutual fund and portfolio management, insurance agency, broker-dealer, fund management, and integrated banking services. The company was incorporated in 1887 and is headquartered in Toronto, Canada.
- Asia wealth and asset management segment expands double digits
- Interest rate cuts pressure life insurance investment spreads
- Long-term care and variable annuity reserves remain key risk
| Net Income: 6.73b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 95.35% < 20% (prev -547.6%; Δ 643.0% < -1%) |
| CFO/TA 0.03 > 3% & CFO 30.8b > Net Income 6.73b |
| Net Debt (-23.8b) to EBITDA (10.8b): -2.20 < 3 |
| Current Ratio: 2.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.67b) vs 12m ago -2.62% < -2% |
| Gross Margin: 31.83% > 18% (prev 53.30%; Δ -21.47% > 0.5%) |
| Asset Turnover: 5.59% > 50% (prev 7.05%; Δ -1.46% > 0%) |
| Interest Coverage Ratio: 6.33 > 6 (EBIT TTM 9.95b / Interest Expense TTM 1.57b) |
| A: 0.05 (Total Current Assets 95.8b - Total Current Liabilities 40.6b) / Total Assets 1094b |
| B: 0.01 (Retained Earnings 5.76b / Total Assets 1094b) |
| C: 0.01 (EBIT TTM 9.95b / Avg Total Assets 1036b) |
| D: 0.05 (Book Value of Equity 53.3b / Total Liabilities 1039b) |
| Altman-Z'' = 0.47 = B |
| DSRI: 3.0 (Receivables 57.9b/2.51b, Revenue 57.9b/69.0b) |
| GMI: 1.67 (GM 53.30% / 31.83%) |
| AQI: 0.95 (AQ_t 0.91 / AQ_t-1 0.96) |
| SGI: 0.84 (Revenue 57.9b / 69.0b) |
| TATA: -0.02 (NI 6.73b - CFO 30.8b) / TA 1094b) |
| Beneish M = -0.92 (Cap -4..+1) = D |
As of August 25, 2026, the stock is trading at USD 42.82 with a total of 1,778,222 shares traded. Over the past week, the price has changed by -2.38%, over one month by -1.13%, over three months by +12.96% and over the past year by +47.74%.
Current recommended Stop Loss: 40.70 (which is 5% or 2.8 ATR below the current price).
Manulife Financial has received a consensus analysts rating of 3.77. Therefore, it is recommended to hold MFC.
- StrongBuy: 3
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 34.7 | -18.9% |
Market Cap CAD = 97.1b (70.5b USD * 1.3784 USD.CAD)
P/E Trailing = 16.3346
P/E Forward = 13.369
P/S = 2.1318
P/B = 2.1445
P/EG = 0.7785
Revenue TTM = 57.9b CAD
EBIT TTM = 9.95b CAD
EBITDA TTM = 10.8b CAD
Long Term Debt = 13.7b CAD (from longTermDebt, last quarter)
Short Term Debt = 383.0m CAD (from shortTermDebt, last quarter)
Debt = 14.1b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.8b CAD (calculated: Debt 14.1b - CCE 37.9b)
Enterprise Value = 73.3b CAD (97.1b + Debt 14.1b - CCE 37.9b)
Interest Coverage Ratio = 6.33 (Ebit TTM 9.95b / Interest Expense TTM 1.57b)
EV/FCF = 2.38x (Enterprise Value 73.3b / FCF TTM 30.8b)
FCF Yield = 41.94% (FCF TTM 30.8b / Enterprise Value 73.3b)
FCF Margin = 53.10% (FCF TTM 30.8b / Revenue TTM 57.9b)
Net Margin = 11.61% (Net Income TTM 6.73b / Revenue TTM 57.9b)
Gross Margin = 31.83% ((Revenue TTM 57.9b - Cost of Revenue TTM 39.5b) / Revenue TTM)
Gross Margin QoQ = 22.37% (prev none%)
Tobins Q-Ratio = 0.07 (Enterprise Value 73.3b / Total Assets 1094b)
Interest Expense / Debt = 11.12% (Interest Expense 1.57b / Debt 14.1b)
Taxrate = 15.58% (1.30b / 8.38b)
NOPAT = 8.40b (EBIT 9.95b * (1 - 15.58%))
Current Ratio = 2.36 (Total Current Assets 95.8b / Total Current Liabilities 40.6b)
Debt / Equity = 0.27 (Debt 14.1b / totalStockholderEquity, last quarter 53.3b)
Debt / EBITDA = -2.20 (Net Debt -23.8b / EBITDA 10.8b)
Debt / FCF = -0.77 (Net Debt -23.8b / FCF TTM 30.8b)
Total Stockholder Equity = 51.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.65% (Net Income 6.73b / Total Assets 1094b)
RoE = 12.99% (Net Income TTM 6.73b / Total Stockholder Equity 51.8b)
RoCE = 15.18% (EBIT 9.95b / Capital Employed (Equity 51.8b + L.T.Debt 13.7b))
RoIC = 0.80% (NOPAT 8.40b / Invested Capital 1051b)
WACC = 8.43% (E(97.1b)/V(111b) * Re(8.29%) + D(14.1b)/V(111b) * Rd(11.12%) * (1-Tc(0.16)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.74 | Cagr: -3.51%
[DCF] Terminal Value 76.11% ; FCFF base≈29.9b ; Y1≈31.9b ; Y5≈38.1b
[DCF] Fair Price = 362.5 (EV 578b - Net Debt -23.8b = Equity 602b / Shares 1.66b; r=8.43% [WACC]; 5y FCF grow 7.52% → 2.50% )
EPS Correlation: 29.38 | EPS CAGR: 3.72% | SUE: 0.09 | # QB: 0
Revenue Correlation: 22.06 | Revenue CAGR: 5.57% | SUE: 0.57 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.20 | Chg30d=+2.43% | Revisions=+55% | Analysts=10
EPS current Year (2026-12-31): EPS=4.51 | Chg30d=+1.23% | Revisions=+40% | GrowthEPS=+7.1% | GrowthRev=-5.6%
EPS next Year (2027-12-31): EPS=4.99 | Chg30d=+1.52% | Revisions=+40% | GrowthEPS=+10.6% | GrowthRev=-8.7%
[Analyst] Revisions Ratio: +51% (up=25, down=7)